High-dose daunorubicin (DNR) for induction and treatment of relapse in acute promyelocytic leukemia (APL): report of 17 cases.
Bobbio Pallavicini
E
E
Luliri
P
P
Anselmetti
L
L
Gorini
M
M
Invernizzi
R
R
Ascari
E
E
D000293:Adolescent; D000328:Adult; D003630:Daunorubicin / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction
D003630:Daunorubicin